Location History:
- Guangdong, CN (2020 - 2022)
- Shenzhen, CN (2022)
Company Filing History:
4 out of 7 
1 out of 4 
1 out of 2 Years Active: 2020-2025
Title: Longqing Tang: Innovator in Cancer Immunotherapy
Introduction
Longqing Tang is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of cancer treatment through his innovative methods and technologies. With a total of 6 patents, Tang is recognized for his groundbreaking work in utilizing activated T cells for cancer therapy.
Latest Patents
One of Tang's latest patents focuses on methods of cancer treatment using activated T cells. This invention provides a method for treating cancer in individuals by employing activated T cells or PBMCs induced by antigen-presenting cells, such as dendritic cells, loaded with a variety of tumor antigen peptides. The method may also include the administration of these antigen-presenting cells to the individual. Furthermore, it allows for precision therapy methods tailored to the individual, utilizing neoantigen peptides or based on the mutation load in the tumor. Additional aspects of this patent include methods for preparing activated T cells, monitoring treatment, and cloning tumor-specific T cell receptors. Another notable patent involves multiple antigen-specific cell therapy methods, which detail the preparation of activated T cells through co-culturing with dendritic cells loaded with tumor antigen peptides. This patent also encompasses methods for treating cancer using these activated T cells, along with pharmaceutical compositions and kits for cell-based cancer immunotherapy.
Career Highlights
Throughout his career, Longqing Tang has worked with notable companies in the biotechnology sector, including Syz Cell Therapy Co. and Hryz Biotech Co. His work has significantly advanced the field of cancer immunotherapy, showcasing his dedication to improving treatment options for patients.
Collaborations
Tang has collaborated with esteemed colleagues, including Xiangjun Zhou and Yanyan Han, further enhancing the impact of his research and innovations in cancer treatment.
Conclusion
Longqing Tang's contributions to cancer immunotherapy through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for new treatment methodologies that could transform cancer care.